Tetraarsenic oxide, a novel orally administrable angiogenesis inhibitor.

International journal of oncology

Volumn 22, Issue 6, 2003, Pages 1271-1276

  Park, Myung Jin ^a   Park, In Chul ^a   Bae, Ill Ju ^a   Seo, Kang Moon ^a   Lee, Seung Hoon ^a   Hong, Seok Il ^a   Eun, Choong Ki ^a   Zhang, Wei ^a   Rhee, Chang Hun ^a  

^a Korea Cancer Center Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ARSENATE SODIUM; ARSENIC ACID DERIVATIVE;

ANIMAL; ARTICLE; C57BL MOUSE; CAPILLARY; CATTLE; CELL CULTURE; CELL CYCLE; CELL MOTION; CYTOLOGY; DRUG EFFECT; LUNG TUMOR; MALE; METASTASIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); ORAL DRUG ADMINISTRATION; RAT; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ADMINISTRATION, ORAL; ANGIOGENESIS INHIBITORS; ANIMALS; ARSENATES; CAPILLARIES; CATTLE; CELL CYCLE; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED;

EID: 0042628219     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.22.6.1271     Document Type: Article

References (0)